Literature DB >> 3107990

Studies on diphosphonate kinetics. Part I: Evaluation of plasma elimination curves during 24 h.

L Hyldstrup, P McNair, P Ring, O Henriksen.   

Abstract

To improve the understanding of diphosphonate affinity to metabolically active bone, the underlying diphosphonate kinetics have been evaluated and compared to Cr-EDTA kinetics. MDP binds to plasma proteins, varying from 25% initially to approximately 70% after 24 h. The renal clearance of diphosphonate is found to be equal to Cr-EDTA clearance. Using simultaneous bolus injection of 99Tc-MDP and 51Cr-EDTA, it has been possible to obtain a coarse estimate of bone uptake of MDP. This uptake is found to correlate well with s-alkaline phosphatase, but since MDP binding to bone is reversible, the plasma elimination curve is not monoexponential. Therefore it has not been possible to describe the uptake of MDP in bone mathematically.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107990     DOI: 10.1007/bf00284529

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  99m Tc-labeled polyphosphate as a skeletal imaging agent.

Authors:  G Subramanian; J G McAfee; E G Bell; R J Blair; R E O'Mara; P H Ralston
Journal:  Radiology       Date:  1972-03       Impact factor: 11.105

2.  Measurements of whole body retention of diphosphonate and other indices of bone metabolism in 125 normals: dependency on age, sex and glomerular filtration.

Authors:  L Hyldstrup; P McNair; G Finn Jensen; N Borg Mogensen; I Transbøl
Journal:  Scand J Clin Lab Invest       Date:  1984-12       Impact factor: 1.713

3.  Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.

Authors:  M Mele; E Conte; A Fratello; D Pasculli; M Pieralice; A D'Addabbo
Journal:  J Nucl Med       Date:  1983-04       Impact factor: 10.057

4.  Accuracy of 24-h whole-body (skeletal) retention of diphosphonate measurements.

Authors:  I Fogelman; R Bessent; J E Scullion; G F Cuthbert
Journal:  Eur J Nucl Med       Date:  1982

5.  Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.

Authors:  G Subramanian; J G McAfee; R J Blair; F A Kallfelz; F D Thomas
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

6.  Normal pharmacokinetics of 99mTc-diphosphonate after intravenous administration.

Authors:  F P Castronovo
Journal:  Biopharm Drug Dispos       Date:  1981 Jul-Sep       Impact factor: 1.627

7.  Studies of skeletal tracer kinetics. IV. Optimum time delay for Tc-99m(Sn) methylene disphosphonate bone imaging.

Authors:  P T Makler; N D Charkes
Journal:  J Nucl Med       Date:  1980-07       Impact factor: 10.057

8.  The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.

Authors:  I Fogelman; R G Bessent; J G Turner; D L Citrin; I T Boyle; W R Greig
Journal:  J Nucl Med       Date:  1978-03       Impact factor: 10.057

9.  Deconvolution analysis of 99mTc-methylene diphosphonate kinetics in metabolic bone disease.

Authors:  J Knop; E Kröger; P Stritzke; C Schneider; H P Kruse
Journal:  Eur J Nucl Med       Date:  1981-02
  9 in total
  3 in total

1.  Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.

Authors:  L Hyldstrup; P McNair; P Ring; O Henriksen
Journal:  Eur J Nucl Med       Date:  1987

Review 2.  Imaging of site specific bone turnover in osteoporosis using positron emission tomography.

Authors:  Glen M Blake; Musib Siddique; Michelle L Frost; Amelia E B Moore; Ignac Fogelman
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

3.  Quantification of 99mTc-DPD concentration in the lumbar spine with SPECT/CT.

Authors:  Michal Cachovan; Alexander Hans Vija; Joachim Hornegger; Torsten Kuwert
Journal:  EJNMMI Res       Date:  2013-06-05       Impact factor: 3.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.